Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parag R Gajendragadkar

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
JACC. Clinical Electrophysiology|February 22, 2020
Scar Tissue: Never Too Old to RemodelClaire A Martin, Parag R Gajendragadkar
Heart (British Cardiac Society)|September 13, 2017
Palpitations in a 72-year-old womanClaire A Martin, Parag R Gajendragadkar, Sharad Agarwal
Heart (British Cardiac Society)|January 8, 2014
Unusual cause of poor response to cardiac resynchronisation therapyClaire A Martin, Parag R Gajendragadkar, Peter J Pugh
European Heart Journal|August 22, 2013
Belts, braces, and pacemaker erosionParag R Gajendragadkar, Holly E Cakebread, Awais M Bokhari
Circulation|November 27, 2023
Making the Right Diagnosis: Slowly but SurelyParag R Gajendragadkar, Claire A Martin, Rohan S Wijesurendra
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|December 23, 2017
Coarse fibrillatory waves in atrial fibrillation predict success of electrical cardioversionTian X Zhao, Claire A Martin, John P Cooper, et al.
BMJ Case Reports|June 14, 2014
Warfarin-induced purple toe syndrome successfully treated with apixabanHolly E Cakebread, Hui Min Knight, Parag R Gajendragadkar, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 8, 2014
Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular diseaseMarie Fisk, Parag R Gajendragadkar, Kaisa M Mäki-Petäjä, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 15, 2015
Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapySérgio Barra, Khang-Li Looi, Parag R Gajendragadkar, et al.
Journal of Clinical Anesthesia|May 18, 2016
Flow rates through intravenous access devices: an in vitro studySaleem I Khoyratty, Pushpaj R Gajendragadkar, Kiran Polisetty, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
JACC. Clinical Electrophysiology|February 22, 2020
Scar Tissue: Never Too Old to RemodelClaire A Martin, Parag R Gajendragadkar
Heart (British Cardiac Society)|September 13, 2017
Palpitations in a 72-year-old womanClaire A Martin, Parag R Gajendragadkar, Sharad Agarwal
Heart (British Cardiac Society)|January 8, 2014
Unusual cause of poor response to cardiac resynchronisation therapyClaire A Martin, Parag R Gajendragadkar, Peter J Pugh
European Heart Journal|August 22, 2013
Belts, braces, and pacemaker erosionParag R Gajendragadkar, Holly E Cakebread, Awais M Bokhari
Circulation|November 27, 2023
Making the Right Diagnosis: Slowly but SurelyParag R Gajendragadkar, Claire A Martin, Rohan S Wijesurendra
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|December 23, 2017
Coarse fibrillatory waves in atrial fibrillation predict success of electrical cardioversionTian X Zhao, Claire A Martin, John P Cooper, et al.
BMJ Case Reports|June 14, 2014
Warfarin-induced purple toe syndrome successfully treated with apixabanHolly E Cakebread, Hui Min Knight, Parag R Gajendragadkar, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 8, 2014
Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular diseaseMarie Fisk, Parag R Gajendragadkar, Kaisa M Mäki-Petäjä, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 15, 2015
Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapySérgio Barra, Khang-Li Looi, Parag R Gajendragadkar, et al.
Journal of Clinical Anesthesia|May 18, 2016
Flow rates through intravenous access devices: an in vitro studySaleem I Khoyratty, Pushpaj R Gajendragadkar, Kiran Polisetty, et al.
Pageof 3